Melatonin as an organoprotector in the stomach and the pancreas

Journal of Pineal Research

Volumn 38, Issue 2, 2005, Pages 73-83

  Jaworek, Jolanta ^a   Brzozowski, Tomasz ^a   Konturek, Stanislaw Jan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Brain gut axis; Caerulein; Gastritis; Gastroprotection; Ischemia reperfusion; l tryptophan; Melatonin; Pancreatoprotection

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; MELATONIN; MELATONIN 2 RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; PANCREAS ENZYME; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRYPTOPHAN;

ACUTE PANCREATITIS; ARACHIDONIC ACID METABOLISM; AUTONOMIC INNERVATION; ENZYME ACTIVITY; ENZYME RELEASE; GASTRITIS; GASTROINTESTINAL TRACT; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HORMONE TRANSPORT; LIPID PEROXIDATION; MEDIATOR RELEASE; MICROCIRCULATION; NEUROTRANSMISSION; NONHUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PINEAL BODY; POSTPRANDIAL STATE; REPERFUSION INJURY; SENSORY NERVE; SHORT SURVEY; STOMACH INJURY; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH ULCER; SYMPATHETIC TONE; ULCER HEALING; VAGUS NERVE; VASCULAR ENDOTHELIUM;

ANIMALS; HUMANS; MELATONIN; PANCREAS; PANCREATITIS; STOMACH; STOMACH ULCER;

EID: 14344250929     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00179.x     Document Type: Short Survey

References (106)

1. LERNER AB, CASE JD, LEE TH, MORI W. Isolation of melatonin, the pineal factor, that lightens melanocytes. J Am Chem Sci 1958; 80:2587.
2. STEFLUJ J, HORNER M. GHOSH M et al. Gene expression of the key enzymes in melatonin synthesis in extrapineal tissues in the rat. J Pineal Res 2001; 30:243-247.
3. REITER RJ. Pineal melatonin: cell biology of its synthesis and its physiological interactions. Endocrine Rev 1991; 12:151-180.
4. PERREAU-LENTZ S, KALSBEEK A, GARIDOU ML et al. Suprachasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms. Eur J Neurosci 2003; 17:221-228.
5. SHARKEY KM. EASTMAN CI. Melatonin phase shifts circadian rhythms in a placebo-controlled stimulated night-work study. Am J Physiol 2002; 282:R454-R463.
6. LUBOVITZKY R, YANAI D, SHEN-ORR Z et al. Daily and seasonal variations in the concentation of melatonin in the human pineal gland. Brain Res 1998; 47:271-278.
7. DUFFY JF, DIJK DJ, HALL EF, CZEISLE CA. Relationship of endogenous circadian melatonin and temperature rhythms to self-reported preference for morning or evening activity in young and old people. J Invest Med 1999; 47:141-150.
8. MERLE A, DELAGRANGE P, RENARD P et al. Effect of melatonin on motility pattern of small intestine in rats and its inhibition by melatonin receptor antagonistS22153. J Pineal Res 2000; 29:116-124.
9. TAN DX, CHEN LD, POEGGLER B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J 1993; 1:57-60.
10. ALLEGRA M, REITER RS, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
11. CHEN Z, CHUA C, GAO J et al. Protective effect of melatonin on myocardial infarction. Am J Physiol, Heart Circ Physiol 2003, 284:H1618-1624.
12. REITER RS, TAND DZ, OSUNA C, GITTO E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7:444-458.
13. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of oxidative enzymes; a significant role for melatonin. J Pineal Res 2004; 36:1-9.
14. DZIEGIEL P, MURAWSKA-CIAŁOWICZ E, JETHON Z et al. Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats of doxorubicin intoxication. J Pineal Res 2003; 35:183-187.
15. JAHOVIC N, CEVIK H, SEHIRLI AO et al. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34:282-287.
16. BERGAMINI CM, GAMBETTI S, DONDI A, CERVELLACI C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004; 10:1611-1626.
17. EMERIT J, EDEAS M, BRICAIRE F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004; 58:39-46.
18. COSTA EJX, LOPES RH, LAMY-FREUND MT. Solubility of pure bilayers to melatonin. J Pineal Res 1995; 19:123-126.
19. GITTO E, ROMEO C, REITER RJ et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004; 39:184-189.
20. DOMINIQUES-RODRIGUES A, ABREU-GONZALES P, GARCIA M et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26:89-93.
21. BONILLA E, VALERO N, CHACIN-BONILLA L, MEDINA-LEENDERTZ S. Melatonin and viral infections. J Pineal Res 2004; 36:73-79.
22. BRENNAN CP, HENDRICK GL, EL-SHEIKH TM, MASHALY MM. Melatonin and the enhancement of immune response in immaturate male chickens. Poult Sci 2002; 81:371-375.
23. REITER RJ, RICHARDSON BA, HURLBUT EC. Pineal, retinal and Harderian gland melatonin in a diurnal species, the Richardson's ground squirrel (Spermophilus richardsonii). Neurosci Lett 1981; 22:285-288.
24. FUKUHARA C, LIU C, IVANOVA TN et al. Gating of the camp signaling cascade and melatonin synthesis by the circadian clock in mammalian retina. J Neurosci 2004; 24:1803-1811.
25. RAIKHLIN NT, KVETNOY IM, TOLKACHEV VN. Melatonin may be synthetized inn enterochromaffine cells. Nature 1975; 255:344-345.
26. BUBENIK GA. Gastrointestinal melatonin, localization, function and clinical relevance. Dig Dis Sci 2002; 10:2336-2348.
27. HUETHER G, POEGGLER B, REIMER A et al. Effects of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992; 51:945-953.
28. BUBENIK GA, PANG SF. Melatonin levels in the gastrointestinal tissues of fish, amphibians and a reptile. Gen Comp Endocrinol 1997; 106:415-419.
29. BUBENIK GA, HACKER RR, BROWN GM, BARTOS L. Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999; 26:56-63.
30. MESSNER M, HUETHER G, LORF T et al. Presence of melatonin in the human hepatobiliary -gastrointestinal tract. Life Sci 200; 69:543-551.
31. TAN DX, MANCHESTER LC, REITER RJ et al. High physiological level of melatonin in the bile of mammals. Life Sci 1999; 65:2523-2529.
32. BUBENIK G. Pinealectomy reduces melatonin levels in the serum, but not in the gastrointestinal tract of the rat. Biol Signals 1977; 6:40-44.
33. HONG GX, PANG SF. N-acetyltransferase activity in the quail (Coturnix coturnix japonica) duodenum. Com Biochem Physiol 1995; 1128:251-255.
34. QUAY WB, MA YH. Demonstration of gastrointestinal hydroxyindole-O-methyl transferase. IRCS Med Sci 1076; 4:563.
35. JAWOREK J, LEJA-SZPAK A, BONIOR J et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overestimulation or ischemia/reperfusion. J Pineal Res 2003; 34:40-52.
36. YOGA K, REITER RJ, RICHARDSON BA. Tryptophan loading increases daytime serum melatonin levels in intact and pine-alectomized rats. Life Sci 1993; 52:1231-1238.
37. BRZOZOWSKI T, KONTUREK PCH, KONTUREK SJ et al. The role of melatonin and its precursor; L-tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia and aspirin. J Pineal Res 1997; 23:79-89.
38. MEESSNER M, HARDELAND R, RODENBECK A, HUETHER G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998; 26:251-259.
39. HATTORI A, MIGITAKA H, IIHO M et al. Identification of melatonin in plants and its effect on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int 1995; 35:627-634.
40. SJOBLOM M, FLEMSTROM G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34:288-293.
41. ILNEROVA H, BURESOVA M, PRESL J. Melatonin rhythm in human milk. J Clin Endocrinol Metab 1993; 77:838-841.
42. DRAGO F, MACAUDA S, SALEHI S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci 2002; 47:1969-1974.
43. LEE PP, PANG SF. Melatonin and its receptors in the gastrointestinal tract. Biol Signals 1993; 2:181-193.
44. HUETHER G. The contribution of extra pineal sites of melatonin synthesis to circulating melatonin levels in higher, vertebrates. Experientia 1993; 49:665-670.
45. HUETHER G, HAJAK G, REIMER A et al. The metabolic fate of infused L-tryptophan in men; possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology 1992; 106:422-432.
46. ZIMMERMANN RC, MCDOUGLE CHJ, SCHUMACHER M et al. Effect of acute tryptophan depletion on nocturnal melatonin secretion in humans. J Clin Endocrinol Metabol 1993; 76:1160-1164.
47. CHO CHH, PANG SF, CHEN BW, PFEIFER CJ. Modulating action of melatonin on serotonin-induced aggravation of ethanol ulceration and changes of mucosal blood Mow in rat stomachs. J Pineal Res 1989; 6:89-97.
48. KONTUREK PC, KONTUREK SJ, MAJKA J et al. Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Eur J Pharmacol 1997; 332:73-77.
49. KONTUREK PC, KONTUREK SJ, BRZOZOWSKI T et al. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischemia- induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32:433-438.
50. BRZOZOWSKI T, KONTUREK PC, KONTUREK SJ et al. The role of melatonin and L-tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia and aspirin. J Pineal Res 1997; 23:79-89.
51. KATO K, MURAI I, ASAI S et al. Protective role of melatonin and pineal gland in modulating water immersion restraint stress ulcer in rats. J Clin Gastroenterol 1998; 27:110-115.
52. DE-LA-LASTRA CA, CABEZA J, MOTILVA V et al. Melatonin protects against gastric ischemia-reperfusion injury in rats. J Pineal Res 1997; 23:47-52.
53. SEWERYNEK E, MELCHIORRI D, CHEN L, REITER RJ. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Rad Biol Med 1995; 19:903-909.
54. SEWERYNEK E, MELCHIORRI D, REITER RJ et al. Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995; 293:327-334.
55. SEWERYNEK E, ORTIZ GG, REITER RJ et al. Lipopolisaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol Cell Endocrinol 1995; 117:183-188.
56. BUBENIK GA, BROWN GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997; 6:40-44.
57. OTSUKA M, KATO K, MURAI I et al. Roles of nocturnal melatonin and the pineal gland in modulation of water-immersion restraint stress-induced gastric mucosal lesions in rats. J Pineal Res 2001; 30:82-86.
58. KATO K, MURAI I, ASAI S et al. Central effect of melatonin against stress-induced gastric ulcers in rats. Neuroreport 1997; 8:2305-2309.
59. BUBENIK GA, AYLES HL, FRINDSHIP RM et al. Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs. J Pineal Res 1998; 24:62-66.
60. BUBENIK GA, BLASK DE, BROWN GM et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998; 7:195-219.
61. KATO K, MURAI I, ASAI S et al. Orcadian rhythm of melatonin and prostaglandin in modulation of stress-induced gastric mucosal lesions in rats. Aliment Pharmacol Ther 2002; 16:29-34.
62. BRZOZOWSKA I, KONTUREK PC, BRZOZOWSKI T et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor, L-tryptophan. J Pineal Res 2002; 32:149-162.
63. DUBOCOVICH ML. Pharmacology and function of melatonin receptors. FASEB J 1988; 2:2765-2773.
64. 2 receptors. Br J Pharmacol 2000; 1129:877-886.
65. WHITTLE BJR, LOPEZ-BELMONTE J, MONCADA S. Regulation of gastric mucosal integrity by endogenous nitric oxide, interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99:607-611.
66. TAKEUCHI K, UESHIMA K, OHUCHI T et al. The role of capsaicin-sensitive sensory neurons in healing of HCl-induced gastric mucosal lesions in rats. Gastroenterology 1994; 106:1524-1532.
67. AKIBA Y, NAKAMURA M, MORI M et al. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat. J Clin Gastroenterol 1998; 27:564-73.
68. TAKAHASHI S, KOBAYASHI N, OKABE S. Regulation by endogenous interleukin-1 of mRNA expression of healing-related factors in gastric ulcers in rats. J Pharmacol Exp Ther 1999; 291:634-641.
69. AKIMOTO M, HASHIMOTO H, SHIGEMOTO M et al. Changes of nitric oxide and growth factors during gastric ulcer healing. J Cardiovasc Pharmacol 2000; 36:5282-285.
70. KONTUREK PC, BRZOZOWSKI T. SULEKOVA Z et al. Role of leptin in ulcer healing. Eur J Pharmacol 2001; 414:87-97.
71. GILAD E, WONG HR, ZINGARELLI B et al. Melatonin expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J 1998; 12:685-693.
72. CRESPO E, MACIAS M, POZO D et al. Melatonin inhibits expression of the inducible NO synthase II in the liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13:1537-1546.
73. MELCHIORRI D, SEWERYNEK E, REITER RJ et al. Suppressive effect of melatonin administration on ethanol-induced gastroduodenal injury in rats in vivo. Br J Pharmacol 1997; 121:264-270.
74. BANDYOPADHYAY D, BISWAS K, BANDYOPADHYAY U et al. Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical. J Pineal Res 2000; 29:143-151.
75. CUZZOCREA S, MAZZON E, SERRAINO I et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30:1-12.
76. BRZOZOWSKI T, KONTUREK SJ, SLIWOWSKI Z et al. Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogens. Digestion 1996; 57:424-432.
77. TRAMANTAMA M. RENZI D, CALABRO A et al. Influence of capsaicin-sensitive afferent fibers on acetic acid induced chronic gastric ulcers in rats. Scand J Gastroenterol 1994; 29:406-413.
78. GRAY IL, BUMUETT NW. ORLOFF SL et al. A role for calcitonin gene-related peptide in protection against gastric ulceration. Ann Surg 1994; 219:58-64.
79. BRZOZOWSKI T, KONTUREK PC, KONTUREK SJ et al. Acceleration of ulcer healing by cholecystokinin (CCK); role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Reg Pept 1999; 82:19-33.
80. KONTUREK SJ, PYTKO-POLONCZYK J, BRZOZOWSKI T et al. Healing of oral and gastric ulcers: effects of blood flow, epidermal growth factor and sensory innervation. Eur J Gastroenterol Hepatol 1993; 5:S45-S52.
81. KONTUREK SJ. Mechanism of gastroprotection. Scand J Gastroenterol 1990; 5:15-28.
82. LI H, HELANDER H. Hypergastrinemia increases proliferation of gastroduodenal epithelium during gastric ulcer healing in rats. Dig Dis Sci 1996; 41:40-48.
83. BRZOZOWSKI T, KONTUREK PC, KONTUREK SJ et al. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol 2000; 51:751-773.
84. KRAUSE DN, BARRIOS VE, DUCLES SP. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 1995; 276:207-213.
85. JAWOREK J, NAWROT K, KONTUREK SJ et al. Melatonin and its precursor; L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36:156-164.
86. LEJA-SZPAK A, JAWOREK J, NAWROT K et al. Modulation of pancreatic enzyme secretion by melatonin or its precursor; L-tryptophan. Role of CCK and afferent nerves. J Physiol Pharmacol 2004; 55:441-451.
87. LI Y, HOA Y, OWYANG C. High affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 1997; 273:G679-G685.
88. JAWOREK J, KONTUREK SJ, SZLACHCIC A. The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat. Int J Pancreatol 1997; 22:137-146.
89. DABROWSKI A, KONTUREK JW, KONTUREK SJ, GABRYELEWICZ A. Role of oxidative stress in the pathogenesis of caerulein-induced pancreatitis. Eur J Pharmacol 1999; 377: 1-11.
90. WITTEL UA, BACHEM M, SIECH M. Oxygen radical production precedes alkohol-induced acute pancreatitis in rats. Pancreas 2003; 26:74-80.
91. PARK BK, CHUNG JB, LEE JH et al. Role of oxygen free radicals in patients with acute pancreatitis. World J Gastroenterol 2003; 9:2266-2269.
92. STEER ML. The pathogenesis and pathophysiology of acute pancreatitis. J Physiol Pharmacol 1998; 49:47-59.
93. JUNGERMANN J, LERCH MM, WEIDENBACH H et al. Disassembly of rat pancreatic acinar cell cytosceleton during supramaximal secretagogue stimulation. Am J Physiol 1995; 268:G328-338.
94. QI W, TAN DX, REITER RJ et al. Melatonin reduced lipid peroxidation and tissue edema in caerulein-induced acute pancreatitis in rats. Dig Dis Sci 1999; 44:2257-2262.
95. JAWOREK J, KONTUREK SJ, LEJA-SZPAK A et al. The circadian rhythm of melatonin modulates the severity of caerulein-induced pancreatitis in the rat. J Pineal Res 2004; 37:161-170.
96. KUHLVEIN E, IRVIN M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cell cytokine expression. J Neuroimmunol 2001; 117:51-57.
97. GARCIA-MAURINO S, POZO D, CALVO JR et al. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 2000; 29:129-137.
98. TOYAMA T, LEWIS MP, KUSSER AM et al. Ischaemia-reperfusion mechanism in acute pancreatitis. Scand J Gastroenterol 1996; 219:20-23.
99. KNOEFEL WT, KOLLIAS N, WARSHAW AL et al. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 1994; 116:904-908.
100. BASSI DG, KOLLIAS N, FERNANDEZ-DELCASTILLO C et al. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg 1994; 179:257-260.
101. WARZECHA Z, DEMBIŃSKI A, JAWOREK J et al. Role of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis. J Physiol Pharmacol 1997; 48:43-58.
102. JAWOREK J, BONIOR J, LEJA-SZPAK A et al. Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin. J Physiol Pharmacol 2002; 53:51-74.
103. LEJA-SZPAK A, JAWOREK J, NAWROT K et al. Melatonin precursor; L-tryptophan protect the pancreas from development of acute pancreatitis though the central site of action. J Physiol Pharmacol 2004; 55:239-254.
104. DUBOCOVICH ML. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1998; 246:902-910.
105. JAWOREK J, KONTUREK SJ, LEJA-SZPAK A et al. Endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53:791-804.
106. TING KN, BLAYLICK NA, SUGDEN D et al. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 1999; 127:987-995.